In 2023, the mortality rate for cervix uteri malignant neoplasms in Brazil stood at approximately 7.04 thousand female deaths. From 2024 to 2028, the forecasted values indicate a consistent increase in mortality, rising from 7.17 to 7.68 thousand deaths. This suggests a rising trend, with an annual growth rate highlighting an increase. The year-on-year change from 2024 to 2025 is approximately 1.81%, and from 2025 to 2026 is around 1.78%, showing consistent growth. Over the five-year period, the compound annual growth rate (CAGR) is about 1.75%.
Future trends to watch include the impact of public health initiatives targeting early detection and vaccination, which may alter this mortality trajectory. Additionally, advancements in treatment methods and increased healthcare access could play critical roles in influencing mortality rates.
